$2.67
+0.13 (+5.12%)
CRVO News2 articles
CervoMed Shares Surge on Patent News, Then Retreat After $10M Stock Offering
CervoMed shares surged to $7.75 after a U.S. patent allowance for neflamapimod in pure DLB, but gave back most gains after announcing a $10 million stock offering at $4 per share. The stock last traded at $4.14, up 8.7%.
CervoMed Stock Surges on Insider-Linked $3M Unit Purchase
CervoMed shares rose over 30% premarket after an SEC filing revealed a trust tied to board chair Joshua S. Boger purchased $3 million in units above Monday's close, signaling insider confidence.